Myocardial Contractile Function and Heart Rate in Mice With Myocyte-Specific Overexpression of Endothelial Nitric Oxide Synthase
- 17 December 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (25), 3097-3102
- https://doi.org/10.1161/hc5001.101966
Abstract
Background — The major source of nitric oxide (NO) in the heart is the constitutive form of NO synthases (eNOS, NOS III) that is expressed in vascular endothelium and cardiac myocytes. NO mediates endothelium-dependent vasodilation and may modulate cardiac function. We examined the role of NO in hearts from transgenic (TG) mice overexpressing eNOS exclusively in cardiac myocytes. Methods and Results — Three independent TG lines with varying levels of NOS activity were selected, and the hearts were isolated and retrogradely perfused at constant flow. We found that NO is positively inotropic in spontaneously beating hearts from wild-type (WT) mice, whereas hearts overexpressing eNOS had reduced basal contractility that was partially reversed by NOS blockade. Heart rate was not altered. Acetylcholine (10 to 1000 nmol/L) increased contractility in unstimulated hearts and decreased contractility after β-adrenergic stimulation with norepinephrine, and these responses were identical in WT and TG hearts. Finally, resting systolic intracellular calcium (Ca 2+ i ) tended to be lower in TG than in WT hearts, and the beat-to-beat responsiveness to Ca 2+ i was reduced in hearts with eNOS overexpression. Conclusions — High levels of endogenous myocyte-derived NO blunt myofilament Ca 2+ sensitivity. The similar effects of acetylcholine on contractility and heart rate, as well as the identical basal intrinsic heart rate in WT and TG hearts, provide a solid argument against NO as an important modulator of neurohormonal control of myocardial function.Keywords
This publication has 18 references indexed in Scilit:
- Calcium Handling and Role of Endothelin-1 in Monocrotaline Right Ventricular Hypertrophy of the RatJournal of Molecular and Cellular Cardiology, 2000
- Assay of Tissue Activity of Nitric Oxide SynthaseCurrent Protocols in Toxicology, 1999
- Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failureJournal of the American College of Cardiology, 1998
- Quantification of Superoxide Radical Formation in Intact Vascular Tissue Using aCypridinaLuciferin Analog as an Alternative to LucigeninBiochemical and Biophysical Research Communications, 1998
- Genetic Expression of Endothelial Nitric Oxide Synthase in Human Atrial MyocardiumMayo Clinic Proceedings, 1996
- Nitric Oxide-dependent Parasympathetic Signaling Is Due to Activation of Constitutive Endothelial (Type III) Nitric Oxide Synthase in Cardiac MyocytesJournal of Biological Chemistry, 1995
- Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.Proceedings of the National Academy of Sciences, 1993
- NGMethyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitroEuropean Journal of Pharmacology, 1992
- Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilatorBritish Journal of Pharmacology, 1988
- Introns increase transcriptional efficiency in transgenic mice.Proceedings of the National Academy of Sciences, 1988